MILESTONE PHARMACEUTICALS IN
MIST·59935V107·US·Common Stock·Healthcare - Biotechnology-13D/G
MIST (MILESTONE PHARMACEUTICALS IN) is held by 45 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($7.5M), TWO SIGMA INVESTMENTS, LP ($2.8M), GOLDMAN SACHS GROUP INC ($2.4M). Net institutional sentiment: Mixed.
45
Holders
Avg rating(12 Elite)
$25M
Total Value
58% (52)
Fund Consensus
26 buying - 19 selling
Who's Trading
ActivistADAdage Capital Management, L.P.6.4%May 13, 2026
InsiderOJOliveto JosephSell $82KApr 16, 2026
ActivistTETrails Edge Capital Partners, LP4.3%Mar 26, 2026
InsiderOJOliveto JosephSell $67KJan 26, 2026
InsiderMLMuller LorenzSell $22KJan 26, 2026
InsiderBDBharucha DavidSell $24KJan 26, 2026
InsiderHAHasija AmitSell $24KJan 26, 2026
InsiderNENelson Jeffrey EdwardSell $24KJan 26, 2026
ActivistPBPropel Bio Management, LLC9.9%Dec 23, 2025
13F: Insider & Congress:
Showing 1-20 of 52
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer